• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[骨髓增殖性综合征中的骨髓活检:细胞定量的预后价值]

[Bone marrow biopsy in myeloproliferative syndromes: prognostic value of cellular quantification].

作者信息

Esquivias López-Cuervo J J, Romero Aguilar A, González García J

机构信息

Servicio de Anatomía Patológica, Ciudad Sanitaria Virgen de las Nieves, Granada.

出版信息

Sangre (Barc). 1990 Apr;35(2):98-101.

PMID:2363101
Abstract

The proportion of granulocytes, erythroblasts, immature cells and megakaryocytes was evaluated when revising the bone-marrow biopsy specimens of 36 patients with myeloproliferative syndromes. These proportions were compared between themselves, a so-called Z value being thus attained; such value resulted from summing the proportion of granulocytes, megakaryocytes and immature cells and subtracting the proportion of erythroblasts. According to its value, above or below the mean, the Z figure correlates with the survival, the difference between both groups appearing as statistically significant (p = 0.02).

摘要

在复查36例骨髓增殖性综合征患者的骨髓活检标本时,对粒细胞、成红细胞、未成熟细胞和巨核细胞的比例进行了评估。将这些比例相互比较,从而得出一个所谓的Z值;该值是通过将粒细胞、巨核细胞和未成熟细胞的比例相加,再减去成红细胞的比例得到的。根据其高于或低于平均值的值,Z值与生存率相关,两组之间的差异具有统计学意义(p = 0.02)。

相似文献

1
[Bone marrow biopsy in myeloproliferative syndromes: prognostic value of cellular quantification].[骨髓增殖性综合征中的骨髓活检:细胞定量的预后价值]
Sangre (Barc). 1990 Apr;35(2):98-101.
2
[Bone-marrow biopsy in chronic myeloid leukemia. Value of the initial examination].
Sem Hop. 1977 Jan 9;53(2):119-24.
3
Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.组织病理学在急性髓系白血病、骨髓增生异常综合征及骨髓增生异常/骨髓增殖性疾病的诊断与分类中的应用
Pathobiology. 2007;74(2):97-114. doi: 10.1159/000101709.
4
[Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].[骨髓活检在慢性骨髓增殖性疾病中的预后价值]
Recenti Prog Med. 2003 Jul-Aug;94(7-8):314-20.
5
[Histopathologic characteristics of bone marrow in patients with aplastic anemia].再生障碍性贫血患者骨髓的组织病理学特征
Srp Arh Celok Lek. 2000 May-Jun;128(5-6):200-4.
6
Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.通过CD34表达检测慢性骨髓增殖性疾病中的血管生成。
Eur J Haematol. 2004 Jun;72(6):410-5. doi: 10.1111/j.1600-0609.2004.00235.x.
7
Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study.早期慢性淋巴细胞白血病骨髓浸润的临床及预后评估(活检与穿刺抽吸对比):一项单中心研究
Haematologica. 1997 May-Jun;82(3):286-90.
8
[The value of the initial bone biopsy in chronic myeloproliferative syndromes. Review of 80 cases].
Sangre (Barc). 1989 Apr;34(2):117-25.
9
[Emperipolesis in megakaryocytes in patients with thrombocytosis in the course of myeloproliferative disorders].[骨髓增殖性疾病过程中血小板增多症患者巨核细胞中的血细胞入胞现象]
Acta Haematol Pol. 1995;26(2):179-83.
10
[Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases].[临床血液学中的Jamshidi活检。1000余例完整活检的方法、适应证及结果,特别提及慢性骨髓增殖性疾病]
Wien Med Wochenschr Suppl. 1986;100:1-24.